-
![]()
10
-
clinical similarity of biosimilar abp 501 to adalimumab in the treatment of patients with moderate to severe plaque psoriasis_ a randomized, double-bl.pdf
- clinical similarity of biosimilar abp 501 to adalimumab in the treatment of patients with moderate to severe plaque psoriasis_ a randomized, double-bl
-
-
![]()
13
-
clinical and regulatory perspectives on biosimilar therapies and intended copies of biologics in rheumatology.pdf.目的临床和监管角度为治疗和副本rheumatology.pd.pdf
- clinical and regulatory perspectives on biosimilar therapies and intended copies of biologics in rheumatology.pdf.目的临床和监管角度为治疗和副本rheumatology.pd
-
-
![]()
10
-
a randomised trial comparing the pharmacokinetics and safety of the biosimilar ct-p6 with reference trastuzumab.[2018][cancer chemother pharmacol][.pdf
- a randomised trial comparing the pharmacokinetics and safety of the biosimilar ct-p6 with reference trastuzumab.[2018][cancer chemother pharmacol][
-
-
![]()
11
-
a pharmacoepidemiological study of the multi-level determinants, predictors, and clinical outcomes of biosimilar epoetin alfa for renal anaemia in haemodialysis patients background and methodology o...pdf
- a pharmacoepidemiological study of the multi-level determinants, predictors, and clinical outcomes of biosimilar epoetin alfa for renal anaemia in haemodialysis patients background and methodology of the monitor-ckd5 study
-
-
![]()
13
-
switching from originator infliximab to biosimilar ct-p13 compared with maintained treatment with originator infliximab (nor-switch) a 52-week, ran.pdf
- switching from originator infliximab to biosimilar ct-p13 compared with maintained treatment with originator infliximab (nor-switch) a 52-week, ran
-
-
![]()
10
-
efficacy and safety of biosimilar sar342434 insulin lispro in adults with type 2 diabetes, also using insulin glargine sorella 2 study.[2018][diabe.pdf
- efficacy and safety of biosimilar sar342434 insulin lispro in adults with type 2 diabetes, also using insulin glargine sorella 2 study.[2018][diabe
-
-
![]()
11
-
effect of a proposed trastuzumab biosimilar compared with trastuzumab on overall response rate in patients with erbb2(her2)-positive metastatic breast.pdf
- effect of a proposed trastuzumab biosimilar compared with trastuzumab on overall response rate in patients with erbb2(her2)-positive metastatic breast
-
-
![]()
22
-
ucm292463 biosimilar guidance webinar ppt.pdf
- ucm292463 biosimilar guidance webinar ppt
-
向豆丁求助：有没有biosimilar?
